The treatment of breast cancer has improved dramatically over the past century, from a
strictly surgical approach to a coordinated one, including local and systemic therapies …

Breast cancer (BC) is a highly heterogeneous disease. The treatment of BC is complicated
owing to intratumoral complexity. Tissue biopsy and immunohistochemistry are the current …

Background The pan-immune-inflammation value (PIV) has been reported as a novel
prognostic biomarker in multiple malignancies. The aim of this study is to investigate the …

Simple Summary Breast cancer is the most common cancer and leading cause of death
worldwide. Therefore, it is important to diagnose and treat breast cancer early. Current …

Gastric cancer remains a leading cause of cancer-related death worldwide, largely due to
inadequate screening methods, late diagnosis, and limited treatment options. Liquid biopsy …

Neoadjuvant endocrine treatment (NET) associates to satisfactory rates of breast
conservative surgery and conversions from inoperable to operable hormone receptor …

The treatment of non-small cell lung cancer (NSCLC) has recently evolved with the
introduction of targeted therapy based on the use of tyrosine kinase inhibitors (TKIs) in …

Liquid biopsies refer to the isolation and analysis of tumor-derived biological material from
body fluids, most commonly blood, in order to provide clinically valuable information for the …

Simple Summary The aim of this review is to evaluate the present status of the use of cell-
free DNA and its fraction of circulating tumor DNA (ctDNA) because this year July 2022, an …

Neoadjuvant treatment of breast cancer is applied to an increasing extent, but treatment
response varies and side effects pose a challenge. The vitamin E isoform delta-tocotrienol …